SILO PHARMA, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
SILO PHARMA, INC. (SILO) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2026-08-13
- SILO PHARMA, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-06-30 was -$1.89K.
- SILO PHARMA, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-03-31 was $2.89K, a 65.08% decline year-over-year.
- SILO PHARMA, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-06-30 was -$1.14K.
- SILO PHARMA, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-03-31 was $8.29K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|
| 2026-06-30 | -$1.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.89K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $169.00 POS AM · filed 2026-04-14 | ||
| 2025-06-30 | -$1.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $7.14K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $8.29K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $8.65K POS AM · filed 2026-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |